Elicio Therapeutics, Inc. Depreciation
Elicio Therapeutics, Inc. (ELTX) reported Depreciation of $100.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-13
- Elicio Therapeutics, Inc. depreciation for the quarter ending 2026-06-30 was $100.00K, a 0.00% change year-over-year.
- Elicio Therapeutics, Inc. depreciation for the quarter ending 2026-03-31 was $46.00K, a 13.21% decline year-over-year.
- Elicio Therapeutics, Inc. depreciation for the quarter ending 2025-12-31 was $49.00K, a 42.35% decline year-over-year.
- Elicio Therapeutics, Inc. depreciation for the quarter ending 2025-09-30 was $100.00K.
- Elicio Therapeutics, Inc. depreciation for fiscal 2025 was $204.00K, a 36.45% decline from fiscal 2024.
- Elicio Therapeutics, Inc. depreciation for fiscal 2024 was $321.00K, a 15.97% decline from fiscal 2023.
- Elicio Therapeutics, Inc. depreciation for fiscal 2023 was $382.00K, a 2.05% decline from fiscal 2022.
- Elicio Therapeutics, Inc. depreciation for fiscal 2022 was $390.00K, a 328.57% increase from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 3 month as first filed | Depreciation 6 month | Depreciation 6 month as first filed | Depreciation 9 month | Depreciation 9 month as first filed | Depreciation 12 month | Depreciation 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $100.00K 10-Q · filed 2026-08-13 | $82.00K 10-Q · filed 2026-08-13 | $195.00K derived: sum of 3 quarters · filed 2026-08-13 | $295.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | $46.00K 10-Q · filed 2026-05-11 | $95.00K derived: sum of 2 quarters · filed 2026-05-11 | $195.00K derived: sum of 3 quarters · filed 2026-05-11 | $295.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | $49.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $149.00K derived: sum of 2 quarters · filed 2026-03-12 | $249.00K derived: sum of 3 quarters · filed 2026-08-13 | $204.00K 10-K · filed 2026-03-12 | ||||
| 2025-09-30 | $100.00K 10-Q · filed 2025-11-13 | $200.00K derived: sum of 2 quarters · filed 2026-08-13 | $155.00K 10-Q · filed 2025-11-13 | $338.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | $100.00K 10-Q · filed 2026-08-13 | $106.00K 10-Q · filed 2026-08-13 | $238.00K derived: sum of 3 quarters · filed 2026-08-13 | $238.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | $53.00K 10-Q · filed 2026-05-11 | $138.00K derived: sum of 2 quarters · filed 2026-05-11 | $138.00K derived: sum of 3 quarters · filed 2026-05-11 | $238.00K derived: sum of 4 quarters · filed 2026-05-11 | ||||
| 2024-12-31 | $85.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $85.00K derived: sum of 2 quarters · filed 2026-03-12 | $185.00K derived: sum of 3 quarters · filed 2026-03-12 | $321.00K 10-K · filed 2026-03-12 | ||||
| 2024-09-30 | $0.00 10-Q · filed 2025-11-13 | $100.00K derived: sum of 2 quarters · filed 2025-11-13 | $236.00K 10-Q · filed 2025-11-13 | $262.00K derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | $100.00K 10-Q · filed 2025-08-07 | $162.00K 10-Q · filed 2025-08-07 | $262.00K derived: sum of 3 quarters · filed 2025-08-07 | $262.00K derived: sum of 4 quarters · filed 2025-08-07 | ||||
| 2024-03-31 | $82.00K 10-Q · filed 2025-05-13 | $162.00K derived: sum of 2 quarters · filed 2025-05-13 | $162.00K derived: sum of 3 quarters · filed 2025-05-13 | $266.00K derived: sum of 4 quarters · filed 2025-05-13 | ||||
| 2023-12-31 | $80.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $80.00K derived: sum of 2 quarters · filed 2025-03-31 | $184.00K derived: sum of 3 quarters · filed 2025-03-31 | $382.00K 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | $0.00 10-Q · filed 2024-11-13 | $104.00K derived: sum of 2 quarters · filed 2024-11-13 | $302.00K 10-Q · filed 2024-11-13 | $314.00K derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2023-06-30 | $104.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $214.00K 10-Q · filed 2024-08-13 | $314.00K derived: sum of 3 quarters · filed 2024-08-13 | $414.00K derived: sum of 4 quarters · filed 2024-08-13 | ||||
| 2023-03-31 | $110.00K 10-Q · filed 2024-05-15 | $22.00K 10-Q · filed 2023-05-10 | $210.00K derived: sum of 2 quarters · filed 2024-05-15 | $310.00K derived: sum of 3 quarters · filed 2024-05-15 | $464.00K derived: sum of 4 quarters · filed 2024-05-15 | |||
| 2022-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $200.00K derived: sum of 2 quarters · filed 2024-03-29 | $354.00K derived: sum of 3 quarters · filed 2024-03-29 | $390.00K 10-K · filed 2024-03-29 | $178.00K 10-K · filed 2023-03-17 | |||
| 2022-09-30 | $100.00K 10-Q · filed 2023-11-13 | $254.00K derived: sum of 2 quarters · filed 2023-11-13 | $290.00K 10-Q · filed 2023-11-13 | $147.00K 10-Q · filed 2022-11-14 | $318.00K derived: sum of 4 quarters · filed 2023-11-13 | |||
| 2022-06-30 | $154.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $186.00K 10-Q · filed 2023-08-14 | $63.00K 10-Q · filed 2022-08-15 | $218.00K derived: sum of 3 quarters · filed 2023-08-14 | $241.00K derived: sum of 4 quarters · filed 2023-08-14 | |||
| 2022-03-31 | $32.00K 10-Q · filed 2023-05-10 | $64.00K derived: sum of 2 quarters · filed 2023-05-10 | $87.00K derived: sum of 3 quarters · filed 2023-05-10 | $110.00K derived: sum of 4 quarters · filed 2023-05-10 | ||||
| 2021-12-31 | $32.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-17 | $55.00K derived: sum of 2 quarters · filed 2023-03-17 | $78.00K derived: sum of 3 quarters · filed 2023-03-17 | $91.00K 10-K · filed 2023-03-17 | ||||
| 2021-09-30 | $23.00K 10-Q · filed 2021-11-12 | $46.00K derived: sum of 2 quarters · filed 2021-11-12 | $59.00K 10-Q · filed 2022-11-14 | $64.00K derived: sum of 4 quarters · filed 2022-05-16 | ||||
| 2021-06-30 | $23.00K 10-Q · filed 2021-08-12 | $29.00K 10-Q · filed 2022-08-15 | $41.00K derived: sum of 3 quarters · filed 2022-05-16 | $88.00K derived: sum of 4 quarters · filed 2022-05-16 | ||||
| 2021-03-31 | $6.00K 10-Q · filed 2022-05-16 | $18.00K derived: sum of 2 quarters · filed 2022-05-16 | $65.00K derived: sum of 3 quarters · filed 2022-05-16 | $112.00K derived: sum of 4 quarters · filed 2022-05-16 | ||||
| 2020-12-31 | $12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $59.00K derived: sum of 2 quarters · filed 2022-03-30 | $106.00K derived: sum of 3 quarters · filed 2022-03-30 | $98.00K 10-K · filed 2022-03-30 | ||||
| 2020-09-30 | $47.00K 10-Q · filed 2021-11-12 | $94.00K derived: sum of 2 quarters · filed 2021-11-12 | $86.00K 10-Q · filed 2021-11-12 | |||||
| 2020-06-30 | $47.00K 10-Q · filed 2021-08-12 | $74.00K 10-Q · filed 2021-08-12 | ||||||
| 2020-03-31 | $27.00K 10-Q · filed 2021-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |